Astralagus-Dioscoreae-Semen Coicis Complex Capsule
Natural health product licensed in Canada
- Other names
- HuangQi-ShanYao-YiYiRen Complex Capsule
- Licence holder
- Endless health Natural Product Ltd.
- NPN or DIN-HM
- 80055107
- Status
- Active licence
- Licence date
- 23 October 2014
- Revision date
- Not provided
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
- Conditions légales
Dioscorea oppositifolia L.: Les matières premières végétales doivent avoir subi les étapes traditionnelles d'épluchage, de lavage et de traitement thermique. L'absence d'alcaloïdes et de composés cyanogènes doit être démontrée par des bulletins d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Schisandra chinensis Source : Schisandra chinensis - fruit Extraction ratio : 70:1 Dry plant equivalent : 840 mg | 12 mg | Not calculated |
| Prunus mume Source : Fruit Extract : Matériel brut sec Extraction ratio : 40:1 Dry plant equivalent : 1,320 mg | 33 mg | Not calculated |
| Crataegus pinnatifida Source : Crataegus pinnatifida, fruit Extraction ratio : 10:1 Dry plant equivalent : 250 mg | 25 mg | Not calculated |
| Dioscorea oppositifolia Source : Dioscorea opposita Rhizome Extraction ratio : 30:1 Dry plant equivalent : 990 mg | 33 mg | Not calculated |
| Astragalus membranaceus Source : Astragalus membranaceus - racine Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 3,400 mg | 68 mg | Not calculated |
| Alisma plantago-aquatica subsp. orientale Source : Tubercule Extraction ratio : 30:1 Dry plant equivalent : 750 mg | 25 mg | Not calculated |
| Anemarrhena asphodeloides Source : Rhizome Extract : Matériel brut sec Extraction ratio : 40:1 Dry plant equivalent : 1,200 mg | 30 mg | Not calculated |
| Lycium barbarum Source : Écorce de racine Extraction ratio : 50:1 Dry plant equivalent : 1,250 mg | 25 mg | Not calculated |
| Scrophularia ningpoensis Source : Racine Extraction ratio : 30:1 Dry plant equivalent : 750 mg | 25 mg | Not calculated |
Non-medicinal ingredients
Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | minimum: 1 Capsule ; maximum: 2 Capsule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Astragalus is traditionally used in Traditional Chinese Medicine (TCM) to augment the protective qi and stabilize the exterior: for deficiency with spontaneous sweating. Astragalus is used in Herbal Medicine to help maintain a healthy immune system. Schisandra is traditionally used in TCM to astringe and secure, tonify qi and engender fluid, tonify the kidney and calm the heart. Astralagus is traditionally used in TCM to tonify the spleen and augment the qi (vital energy): for spleen deficiency presenting with the lack of appetite, fatigue, and diarrhea. Astralagus is traditionally used in TCM to tonify the lungs and is used for frequent colds.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80055107
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.